Greg Zante
Chief Financial Officer · Viking Therapeutics, Inc.
- 2024
- Jul 30, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Greg Zante files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian Lian - $14.00M in VKTX purchases and sales in the last 12 months
- Marianna Mancini - $2.73M in VKTX purchases and sales in the last 12 months
- Charles A. Rowland Jr. - $2.13M in VKTX purchases and sales in the last 12 months
- Matthew W. Foehr - $562K in VKTX purchases and sales in the last 12 months
- Neil William Aubuchon - $150K in VKTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Greg Zante?
Greg Zante is a corporate insider, tracked as Chief Financial Officer of Viking Therapeutics, Inc. (VKTX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Greg Zante submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Greg Zante been buying or selling stock?
Recorded transactions: 0 open-market purchases and 15 open-market sales ($13.03M) across all tracked filings.
